CHRISTOPHER ACEVEDO-RAMOS: Open Payments
NPI 1407535008 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 23 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $793 · 2025 $477
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Novo Nordisk Inc | 3 | $63 |
| SANOFI-AVENTIS U.S. LLC | 3 | $62 |
| Exact Sciences Corporation | 2 | $58 |
| ABBVIE INC. | 2 | $47 |
| Corcept Therapeutics | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| PFIZER INC. | 1 | $18 |
Products named: AIRSUPRA, TZIELD, The Cologuard Plus Collection Kit, Korlym, JARDIANCE, Ozempic, QULIPTA, TEPEZZA.
Industry payments across FL — which companies pay providers there.
